Rafael Parra‐Medina

841 total citations
82 papers, 436 citations indexed

About

Rafael Parra‐Medina is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rafael Parra‐Medina has authored 82 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Rafael Parra‐Medina's work include Cancer Genomics and Diagnostics (6 papers), COVID-19 Clinical Research Studies (6 papers) and Cancer-related molecular mechanisms research (6 papers). Rafael Parra‐Medina is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), COVID-19 Clinical Research Studies (6 papers) and Cancer-related molecular mechanisms research (6 papers). Rafael Parra‐Medina collaborates with scholars based in Colombia, United States and Spain. Rafael Parra‐Medina's co-authors include Adriana Rojas‐Villarraga, Sabrina Herrera, Édgar Garavito, Arley Gómez-López, Nicolás Molano‐González, Nancy Agmon‐Levin, Juan‐Manuel Anaya, Yehuda Shoenfeld, Vladimir Valera and Peter A. Pinto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Rafael Parra‐Medina

65 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Parra‐Medina Colombia 11 102 101 96 80 76 82 436
Takeo Naito Japan 12 125 1.2× 53 0.5× 103 1.1× 99 1.2× 46 0.6× 45 565
Puo‐Hsien Le Taiwan 12 75 0.7× 134 1.3× 125 1.3× 145 1.8× 50 0.7× 78 454
Xiaocheng Cheng China 12 83 0.8× 72 0.7× 47 0.5× 83 1.0× 185 2.4× 29 604
Mariko Negi Japan 13 82 0.8× 176 1.7× 134 1.4× 116 1.4× 20 0.3× 30 584
Sangjoon Choi South Korea 15 124 1.2× 176 1.7× 83 0.9× 159 2.0× 71 0.9× 63 681
Dan Assaf Israel 9 74 0.7× 164 1.6× 39 0.4× 159 2.0× 52 0.7× 34 497
Daniela Lenggenhager Switzerland 14 63 0.6× 214 2.1× 120 1.3× 174 2.2× 67 0.9× 38 582
Satoshi Shiba Japan 12 150 1.5× 238 2.4× 84 0.9× 174 2.2× 15 0.2× 32 467
Sahar Lotfi‐Emran United States 10 74 0.7× 57 0.6× 39 0.4× 98 1.2× 159 2.1× 15 465

Countries citing papers authored by Rafael Parra‐Medina

Since Specialization
Citations

This map shows the geographic impact of Rafael Parra‐Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Parra‐Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Parra‐Medina more than expected).

Fields of papers citing papers by Rafael Parra‐Medina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Parra‐Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Parra‐Medina. The network helps show where Rafael Parra‐Medina may publish in the future.

Co-authorship network of co-authors of Rafael Parra‐Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Parra‐Medina. A scholar is included among the top collaborators of Rafael Parra‐Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Parra‐Medina. Rafael Parra‐Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Parra‐Medina, Rafael, et al.. (2025). Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse Population. Clinical Lung Cancer. 26(5). e342–e352.
3.
Tsao, Hui‐Mei, Liliana López-Kleine, Diego A. Bonilla, et al.. (2025). Integrative Transcriptomic Meta-Analysis Reveals Risk Signatures and Immune Infiltration Patterns in High-Grade Serous Ovarian Cancer. SHILAP Revista de lepidopterología. 5(3). 23–23.
4.
Tsao, Hui‐Mei, et al.. (2025). Transcriptional landscape of pleural mesothelioma patients in relation to NF2 gene mutational status. Journal of the Egyptian National Cancer Institute. 37(1). 25–25.
5.
Riaño-Moreno, Julián C., et al.. (2024). Globalization of a telepathology network with artificial intelligence applications in Colombia: The GLORIA program study protocol. Journal of Pathology Informatics. 15. 100394–100394. 5 indexed citations
6.
González, D., et al.. (2024). HER2-low prevalence among Hispanic/Latino women with breast cancer: A systematic review and meta-analysis. PLoS ONE. 19(12). e0315287–e0315287. 1 indexed citations
7.
Castaño, Carlos, et al.. (2024). ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemia. Frontiers in Immunology. 15. 1473909–1473909. 3 indexed citations
8.
Ordóñez-Rubiano, Edgar G., Alba Lucía Cómbita, Matías Baldoncini, et al.. (2024). Cellular Senescence in Diffuse Gliomas: From Physiopathology to Possible Treatments. World Neurosurgery. 191. 138–148. 2 indexed citations
9.
Cuervo, Sonia Isabel, et al.. (2023). Fusariosis en pacientes con cáncer: serie de 13 casos y revisión de la literatura. Biomédica. 43(Sp. 1). 41–56.
10.
Parra‐Medina, Rafael, et al.. (2023). EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLS. Experimental Oncology. 44(2). 137–141.
11.
Sarmiento-Monroy, Juan Camilo, Rafael Parra‐Medina, Édgar Garavito, & Adriana Rojas‐Villarraga. (2021). T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications. Viral Immunology. 34(3). 190–200. 10 indexed citations
12.
Garavito, Édgar, et al.. (2021). Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Reumatología Clínica (English Edition). 17(7). 371–375. 9 indexed citations
13.
Ribera‐Cortada, Inmaculada, Isabel Trias, Luis Veloza, et al.. (2021). Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review. International Journal of Molecular Sciences. 23(1). 251–251. 18 indexed citations
14.
Parra‐Medina, Rafael, Liliana López-Kleine, Sandra Ramírez‐Clavijo, & César Payán‐Gómez. (2020). Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis. Scientific Reports. 10(1). 12345–12345. 9 indexed citations
15.
Vásquez‐Hoyos, Pablo, et al.. (2020). Agreement between the Clinical and Autopsy Results of Children Who Died with Pneumonia in Pediatric Intensive Care. Journal of Pediatric Intensive Care. 11(1). 26–31. 1 indexed citations
16.
Parra‐Medina, Rafael, et al.. (2020). Interpretación de la biopsia de glándula salival menor en el síndrome de Sjögren. Correlación clínico-patológica. Revista Colombiana de Reumatología. 27. 82–89. 1 indexed citations
17.
Álzate, Juan Pablo, et al.. (2019). A Systematic review and Meta‐Analysis of the survival and clinicopathological features of p63 expression in Merkel cell carcinoma. Australasian Journal of Dermatology. 61(3). e276–e282. 9 indexed citations
18.
Parra‐Medina, Rafael, et al.. (2018). Ewing′s sarcoma metastatic to skin: a case report and review of the literature. International Journal of Dermatology. 57(11). 1365–1368. 1 indexed citations
19.
20.
Parra‐Medina, Rafael, et al.. (2013). Cytokines, chemokines and growth factors. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeo Naito Breakdown of academic impact, for papers by Puo‐Hsien Le Breakdown of academic impact, for papers by Xiaocheng Cheng Breakdown of academic impact, for papers by Mariko Negi Breakdown of academic impact, for papers by Sangjoon Choi Breakdown of academic impact, for papers by Dan Assaf Breakdown of academic impact, for papers by Daniela Lenggenhager Breakdown of academic impact, for papers by Satoshi Shiba Breakdown of academic impact, for papers by Sahar Lotfi‐Emran
Rankless by CCL
2026